Market
Abram snags $8.3M US DoD contract to advance blood coagulation diagnostic
Abram secured an $8.3 million US Department of Defense contract to advance its blood coagulation diagnostic technology. The award follows the company's $10.75 million financing round completed in February and supports progress toward an FDA filing for the diagnostic device.
The source
This brief is a MedIndexer summary of reporting by Medical Device Network. To read the full story, head to the source.
Read the full story at Medical Device Network